CRIS Current Research Information System

RE, MARIA CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.130
EU - Europa 5.561
AS - Asia 1.702
AF - Africa 422
SA - Sud America 23
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.117
GB - Regno Unito 1.209
IT - Italia 1.157
SE - Svezia 1.067
DE - Germania 811
CN - Cina 638
VN - Vietnam 568
IN - India 321
IE - Irlanda 266
UA - Ucraina 249
FR - Francia 215
TG - Togo 182
RU - Federazione Russa 175
ZA - Sudafrica 99
BG - Bulgaria 84
EE - Estonia 83
JO - Giordania 81
NG - Nigeria 64
CI - Costa d'Avorio 56
BE - Belgio 51
CH - Svizzera 40
AT - Austria 26
FI - Finlandia 24
HR - Croazia 24
HK - Hong Kong 21
SC - Seychelles 17
NL - Olanda 15
PT - Portogallo 14
IR - Iran 13
BR - Brasile 11
CA - Canada 11
JP - Giappone 11
RO - Romania 10
UZ - Uzbekistan 10
AU - Australia 9
SG - Singapore 9
CL - Cile 8
ES - Italia 7
LB - Libano 7
PL - Polonia 7
TR - Turchia 7
CZ - Repubblica Ceca 6
GR - Grecia 6
PH - Filippine 5
EU - Europa 4
IL - Israele 4
NZ - Nuova Zelanda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
EG - Egitto 3
MK - Macedonia 3
BD - Bangladesh 2
HU - Ungheria 2
MY - Malesia 2
AL - Albania 1
AR - Argentina 1
BO - Bolivia 1
EC - Ecuador 1
ID - Indonesia 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MS - Montserrat 1
MX - Messico 1
NO - Norvegia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
Totale 14.858
Salva come PNG Salva come JPEG
Città #
Southend 1.082
Fairfield 909
Chandler 736
Ashburn 581
Ann Arbor 497
Woodbridge 433
Seattle 419
Dong Ket 410
Houston 408
Wilmington 372
Princeton 337
Cambridge 324
Dublin 266
Bologna 230
Lomé 182
Jacksonville 147
Frankfurt am Main 130
Westminster 130
Nanjing 121
Berlin 109
Padova 94
Turin 87
Redmond 84
Sofia 82
Amman 81
Beijing 71
San Diego 68
Florence 67
Abeokuta 63
Des Moines 63
Jinan 60
Abidjan 56
Shenyang 56
Saint Petersburg 53
Bremen 51
Milan 50
New York 49
Brussels 48
Hebei 46
Boardman 36
Mülheim 31
Dearborn 29
Falls Church 29
Nanchang 29
Olalla 29
Bern 28
Redwood City 28
Tianjin 28
Rome 25
Changsha 22
Paris 22
London 21
Vienna 20
Bühl 19
Hangzhou 19
Helsinki 19
Los Angeles 19
Monmouth Junction 19
Jiaxing 18
Ningbo 18
Taiyuan 16
Zhengzhou 16
Lanzhou 15
Mahé 15
Phoenix 15
Norwalk 14
Haikou 13
Kuban 13
Chicago 12
Hong Kong 12
Medford 12
Verona 12
Atlanta 11
Kunming 11
Pune 11
San Venanzo 11
Naples 10
Taizhou 10
Costa Mesa 9
Muizenberg 9
Napoli 9
Ardabil 8
Cagliari 8
Ferrara 8
Guangzhou 8
San Jose 8
Amsterdam 7
Hefei 7
San Francisco 7
Washington 7
Brescia 6
Formigine 6
Istanbul 6
Leawood 6
Reggio Nell'emilia 6
Rubano 6
São Paulo 6
Tokyo 6
Toronto 6
Clearwater 5
Totale 9.943
Salva come PNG Salva come JPEG
Nome #
Analisi della trasmissione di SARS-CoV-2: influenza delle condizioni termoigrometriche rispetto al rischio di diffusione del contagio 220
ALTERAZIONI DEL MICROBIOMA FARINGEO IN CORSO DI INFEZIONI DA NEISSERIA GONORRHOEAE 200
Acute onset myopericarditis as unusual presentation of primary HIV infection 179
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells 165
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? 165
RILEVAZIONE DELLA STRUTTURA MOSAICO DEL GENE PENA IN SEDE ORO-FARINGEA 164
Impact of meropenem on Klebsiella pneumoniae metabolism 162
Pharyngeal Chlamydia and gonorrhea: a hidden problem 157
Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? 154
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 151
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. 150
Comparison of the Aptima HIV-1 Quant Dx Assay with the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 v2.0 Test for HIV-1 Viral Load Quantification in Plasma Samples from HIV-1-Infected Patients. 149
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 147
Discordant resistance interpretations in multi-treated HIV-1 patients 142
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 139
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 138
Autochthonous cases of mucosal leishmaniasis in Northeastern Italy: clinical management and novel treatment approaches 138
Mosaic structure of the penA gene in the oropharynx of men who have sex with men negative for gonorrhoea 137
IFI16 expression is related to selected transcription factors during B-cell differentiation 132
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 131
HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. 129
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 128
Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples 123
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 123
Antiretroviral molecules and cardiovascular diseases. 122
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 121
Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection 121
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 120
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures 119
Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. 118
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 118
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells 118
Detection of serum antibodies to human intracisternal A-type retroviral particles in chronic idiopathic urticaria 117
HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR. 117
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. 117
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 117
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 116
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 115
Asymptomatic Leishmania infantum infection in blood donors living in an endemic area, northeastern Italy 115
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 114
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz 114
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 114
Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients. 113
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 113
null 113
HIV-1 subtype C transmission network: The phylogenetic reconstruction strongly supports the epidemiological data. 113
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 112
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 112
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 112
HIV-related mechanisms in atherosclerosis and cardiovascular diseases. 110
Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy. 110
An imported case of adult T cell leukemia in a HTLV-I-infected patient in Italy. 109
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 109
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy 108
Effects of Antiretroviral Molecules on Survival and Gene Expression of an Osteoblast-like Cell Line 108
Rectal Microbiota Associated With Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Having Sex With Other Men 108
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 107
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 107
Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results 107
Host restriction factors and Human immunodeficiency Virus (HIV-1): a dynamic interplay involving all phases of the viral life cycle 107
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. 106
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 106
Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. 105
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 103
Different patterns of HIV-1 DNA after therapy discontinuation 103
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report. 103
Bone alterations during HIV infection 103
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 102
Cap. 4- IL MICROBIOMA OCULARE E IMPATTO SUL SISTEMA IMMUNE 102
Guidelines for the qualitative detection of viral genomes in dried blood spots. 101
SARS-CoV-2/COVID-19 testing: The tower of babel 101
Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine. 100
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 100
HIV and kidney: A dangerous liaison 99
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 99
Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy 99
Comparison of MycoPrep and the new MYCO-TB kit: rapid and efficient digestion and decontamination of respiratory specimens for the detection of Mycobacteria 99
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 99
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study 98
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. 97
High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method. 97
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 97
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients 97
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy 96
Pre-Pregnancy Diet and Vaginal Environment in Caucasian Pregnant Women: An Exploratory Study 96
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 95
Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures. 94
Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management. 94
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 93
Simultaneous detection of HCV and HIV-1 by SYBR Green real time multiplex RT-PCR technique in plasma samples. 92
Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection. 90
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. 89
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 89
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation. 89
Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates 89
HIV-1 tat protein and cell proliferation and survival: a brief review. 88
V3 net charge: additional tool in HIV-1 tropism prediction 88
Metabolic bone disease in HIV infection 87
Nevirapine prophylaxis to prevent HIV-1 mother-to-child transmission: pharmacokinetic considerations in preterm infants 86
Quantitative HIV-1 proviral DNA detection: a multicentre analysis. 85
Totale 11.570
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019321 0 0 0 0 0 0 0 0 0 124 50 147
2019/20203.335 416 80 34 186 347 323 397 447 496 248 198 163
2020/20212.662 488 144 141 109 89 140 47 130 312 170 127 765
2021/20223.542 245 194 205 414 295 188 73 228 132 463 630 475
2022/20233.753 398 525 219 508 286 241 106 219 617 136 321 177
2023/2024980 74 166 83 119 89 219 70 71 22 67 0 0
Totale 15.366